Fingerprint
Dive into the research topics of 'Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?
David Grimwade, Sylvie D Freeman
Research output: Contribution to journal › Article › peer-review
42
Citations
(Scopus)